Hepatitis C virus inhibitors

Details Hepatitis C virus inhibitors Hepatitis C virus inhibitors

2006-07-06

2009-10-13

Tsang, Cecilia (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

Reexamination Certificate

active

07601686

ABSTRACT:
The present disclosure relates to tripeptide compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.

REFERENCES:
patent: 2005/0153877 (2005-07-01), Miao et al.
patent: 2006/0172950 (2006-08-01), Wang et al.
patent: 2006/0199773 (2006-09-01), Sausker et al.
patent: WO 98/17679 (1998-04-01), None
patent: WO 99/07733 (1999-02-01), None
patent: WO 99/07734 (1999-02-01), None
patent: WO 00/09543 (2000-02-01), None
patent: WO 00/09558 (2000-02-01), None
patent: WO 00/59929 (2000-10-01), None
patent: WO 02/060926 (2002-08-01), None
patent: WO 03/053349 (2003-07-01), None
patent: WO 03/064416 (2003-08-01), None
patent: WO 03/064455 (2003-08-01), None
patent: WO 03/064456 (2003-08-01), None
patent: WO 03/066103 (2003-08-01), None
patent: WO 03/099274 (2003-12-01), None
patent: WO 03/099316 (2003-12-01), None
patent: WO 2004/009121 (2004-01-01), None
patent: WO 2004/032827 (2004-04-01), None
patent: WO 2004/037855 (2004-05-01), None
patent: WO 2004/043339 (2004-05-01), None
patent: WO 2004/072243 (2004-08-01), None
patent: WO 2004/093798 (2004-11-01), None
patent: WO 2004/093915 (2004-11-01), None
patent: WO 2004/094452 (2004-11-01), None
patent: WO 2004/101602 (2004-11-01), None
patent: WO 2004/101605 (2004-11-01), None
patent: WO 2004/103996 (2004-12-01), None
patent: WO 2004/113365 (2004-12-01), None
patent: WO 2005/010029 (2005-02-01), None
patent: WO 2005/028501 (2005-03-01), None
patent: WO 2005/037214 (2005-04-01), None
patent: WO 2005/037860 (2005-04-01), None
patent: WO 2005/046712 (2005-05-01), None
patent: WO 2005/051410 (2005-06-01), None
patent: WO 2005/051980 (2005-06-01), None
patent: WO 2005/054430 (2005-06-01), None
patent: WO 2005/070955 (2005-08-01), None
patent: WO 2005/073216 (2005-08-01), None
patent: WO 2005/095403 (2005-10-01), None
patent: WO 2005/116054 (2005-12-01), None
patent: WO 2006/000085 (2006-01-01), None
patent: WO 2006/007700 (2006-01-01), None
patent: WO 2006/007708 (2006-01-01), None
patent: WO 2006/016930 (2006-02-01), None
patent: WO 2006/020276 (2006-02-01), None
patent: WO 2006/026352 (2006-03-01), None
patent: WO 2006/033878 (2006-03-01), None
patent: WO 2006/043145 (2006-04-01), None
patent: WO 2006/086381 (2006-08-01), None
patent: WO 2006/096652 (2006-09-01), None
patent: WO 2006/119061 (2006-11-01), None
patent: WO 2006/122188 (2006-11-01), None
U.S. Appl. No. 11/591,253, filed Nov. 1, 2006, D'Andrea, et al.
U.S. Appl. No. 11/415,722, filed May 2, 2006, Wenying Li.
U.S. Appl. No. 11/546,505, filed Oct. 11, 2006, Carini, et al.
Lauer, G.M. and Walker, B.D., “Hepatitis C Virus Infection”,N. Engl. J. Med., 2001, 345, 41-52.
Poupart, M.-A., Cameron, D.R., Chabot, C., Ghiro, E., Goudreau, N., Boulet, S., Poirier, M., and Tsantrizos, Y.S., “Solid-Phase Synthesis of Peptidomimetic Inhibitors for the Hepatitis C Virus NS3 Protease”,J. Org. Chem., 2001, 66, 4743-4751.

Affiliated with

Also associated with

Rating

Hepatitis C virus inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hepatitis C virus inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hepatitis C virus inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4095402